A citation-based method for searching scientific literature

Seth Carbonneau, Sujata Sharma, Liaomin Peng, Vaisakh Rajan, Dominik Hainzl, Martin Henault, Chian Yang, Jacob Hale, Janine Shulok, John Tallarico, Jeff Porter, Jennifer L Brogdon, Glenn Dranoff, James E Bradner, Marc Hild, Carla P Guimaraes. Cell Chem Biol 2021
Times Cited: 6







List of co-cited articles
42 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide.
Max Jan, Irene Scarfò, Rebecca C Larson, Amanda Walker, Andrea Schmidts, Andrew A Guirguis, Jessica A Gasser, Mikołaj Słabicki, Amanda A Bouffard, Ana P Castano,[...]. Sci Transl Med 2021
52
100

The dTAG system for immediate and target-specific protein degradation.
Behnam Nabet, Justin M Roberts, Dennis L Buckley, Joshiawa Paulk, Shiva Dastjerdi, Annan Yang, Alan L Leggett, Michael A Erb, Matthew A Lawlor, Amanda Souza,[...]. Nat Chem Biol 2018
276
66

HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins.
Dennis L Buckley, Kanak Raina, Nicole Darricarrere, John Hines, Jeffrey L Gustafson, Ian E Smith, Afjal H Miah, John D Harling, Craig M Crews. ACS Chem Biol 2015
192
66

A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.
Laura A Banaszynski, Ling-Chun Chen, Lystranne A Maynard-Smith, A G Lisa Ooi, Thomas J Wandless. Cell 2006
575
50

The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K.
Mikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, Yen-Der Li, Manisha Manojkumar, Richard D Bunker, Katherine A Donovan, Quinlan L Sievers, Jonas Koeppel, Dakota Suchyta,[...]. Nature 2020
101
50

Small-molecule-induced polymerization triggers degradation of BCL6.
Mikołaj Słabicki, Hojong Yoon, Jonas Koeppel, Lena Nitsch, Shourya S Roy Burman, Cristina Di Genua, Katherine A Donovan, Adam S Sperling, Moritz Hunkeler, Jonathan M Tsai,[...]. Nature 2020
57
50

Peptidic degron for IMiD-induced degradation of heterologous proteins.
Vidyasagar Koduri, Samuel K McBrayer, Ella Liberzon, Adam C Wang, Kimberly J Briggs, Hyejin Cho, William G Kaelin. Proc Natl Acad Sci U S A 2019
18
50

An auxin-based degron system for the rapid depletion of proteins in nonplant cells.
Kohei Nishimura, Tatsuo Fukagawa, Haruhiko Takisawa, Tatsuo Kakimoto, Masato Kanemaki. Nat Methods 2009
840
50

Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN.
Quinlan L Sievers, Georg Petzold, Richard D Bunker, Aline Renneville, Mikołaj Słabicki, Brian J Liddicoat, Wassim Abdulrahman, Tarjei Mikkelsen, Benjamin L Ebert, Nicolas H Thomä. Science 2018
161
50

Tunable and reversible drug control of protein production via a self-excising degron.
Hokyung K Chung, Conor L Jacobs, Yunwen Huo, Jin Yang, Stefanie A Krumm, Richard K Plemper, Roger Y Tsien, Michael Z Lin. Nat Chem Biol 2015
114
50

Unifying principles of bifunctional, proximity-inducing small molecules.
Christopher J Gerry, Stuart L Schreiber. Nat Chem Biol 2020
53
33

Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins.
Taavi K Neklesa, Hyun Seop Tae, Ashley R Schneekloth, Michael J Stulberg, Timothy W Corson, Thomas B Sundberg, Kanak Raina, Scott A Holley, Craig M Crews. Nat Chem Biol 2011
199
33

Lysosome-targeting chimaeras for degradation of extracellular proteins.
Steven M Banik, Kayvon Pedram, Simon Wisnovsky, Green Ahn, Nicholas M Riley, Carolyn R Bertozzi. Nature 2020
161
33

Harnessing the Power of Proteolysis for Targeted Protein Inactivation.
Rati Verma, Dane Mohl, Raymond J Deshaies. Mol Cell 2020
83
33

Identification of a primary target of thalidomide teratogenicity.
Takumi Ito, Hideki Ando, Takayuki Suzuki, Toshihiko Ogura, Kentaro Hotta, Yoshimasa Imamura, Yuki Yamaguchi, Hiroshi Handa. Science 2010
33

Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome.
Katherine A Donovan, Jian An, Radosław P Nowak, Jingting C Yuan, Emma C Fink, Bethany C Berry, Benjamin L Ebert, Eric S Fischer. Elife 2018
174
33

Plasticity in binding confers selectivity in ligand-induced protein degradation.
Radosław P Nowak, Stephen L DeAngelo, Dennis Buckley, Zhixiang He, Katherine A Donovan, Jian An, Nozhat Safaee, Mark P Jedrychowski, Charles M Ponthier, Mette Ishoey,[...]. Nat Chem Biol 2018
203
33

Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
Daniel P Bondeson, Blake E Smith, George M Burslem, Alexandru D Buhimschi, John Hines, Saul Jaime-Figueroa, Jing Wang, Brian D Hamman, Alexey Ishchenko, Craig M Crews. Cell Chem Biol 2018
310
33

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.
Ting Han, Maria Goralski, Nicholas Gaskill, Emanuela Capota, Jiwoong Kim, Tabitha C Ting, Yang Xie, Noelle S Williams, Deepak Nijhawan. Science 2017
261
33

SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate.
Mary E Matyskiela, Suzana Couto, Xinde Zheng, Gang Lu, Julia Hui, Katie Stamp, Clifton Drew, Yan Ren, Maria Wang, Aaron Carpenter,[...]. Nat Chem Biol 2018
118
33


The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins.
Gang Lu, Richard E Middleton, Huahang Sun, MarkVic Naniong, Christopher J Ott, Constantine S Mitsiades, Kwok-Kin Wong, James E Bradner, William G Kaelin. Science 2014
855
33

PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network.
Kurt M Reichermeier, Ronny Straube, Justin M Reitsma, Michael J Sweredoski, Christopher M Rose, Annie Moradian, Willem den Besten, Trent Hinkle, Erik Verschueren, Georg Petzold,[...]. Mol Cell 2020
24
33

Heterobifunctional Molecules Induce Dephosphorylation of Kinases-A Proof of Concept Study.
Sayumi Yamazoe, Jeffrey Tom, Yue Fu, Wenqiong Wu, Liang Zeng, Changlei Sun, Qi Liu, Jie Lin, Kui Lin, Wayne J Fairbrother,[...]. J Med Chem 2020
40
33

Catalytic in vivo protein knockdown by small-molecule PROTACs.
Daniel P Bondeson, Alina Mares, Ian E D Smith, Eunhwa Ko, Sebastien Campos, Afjal H Miah, Katie E Mulholland, Natasha Routly, Dennis L Buckley, Jeffrey L Gustafson,[...]. Nat Chem Biol 2015
547
33

Selective degradation of splicing factor CAPERα by anticancer sulfonamides.
Taisuke Uehara, Yukinori Minoshima, Koji Sagane, Naoko Hata Sugi, Kaoru Ogawa Mitsuhashi, Noboru Yamamoto, Hiroshi Kamiyama, Kentaro Takahashi, Yoshihiko Kotake, Mai Uesugi,[...]. Nat Chem Biol 2017
184
33

Chemically induced proximity in biology and medicine.
Benjamin Z Stanton, Emma J Chory, Gerald R Crabtree. Science 2018
136
33

Targeted protein degradation and the enzymology of degraders.
Stewart L Fisher, Andrew J Phillips. Curr Opin Chem Biol 2018
61
33

Targeted protein degradation: expanding the toolbox.
Matthieu Schapira, Matthew F Calabrese, Alex N Bullock, Craig M Crews. Nat Rev Drug Discov 2019
287
33

Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction.
Kyle R Simonetta, Joshua Taygerly, Kathleen Boyle, Stephen E Basham, Chris Padovani, Yan Lou, Thomas J Cummins, Stephanie L Yung, Szerenke Kiss von Soly, Frank Kayser,[...]. Nat Commun 2019
56
33

Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6.
Nina Kerres, Steffen Steurer, Stefanie Schlager, Gerd Bader, Helmut Berger, Maureen Caligiuri, Christian Dank, John R Engen, Peter Ettmayer, Bernhard Fischerauer,[...]. Cell Rep 2017
81
33

A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader.
Hai-Tsang Huang, Dennis Dobrovolsky, Joshiawa Paulk, Guang Yang, Ellen L Weisberg, Zainab M Doctor, Dennis L Buckley, Joong-Heui Cho, Eunhwa Ko, Jaebong Jang,[...]. Cell Chem Biol 2018
196
33

A Chemical Switch System to Modulate Chimeric Antigen Receptor T Cell Activity through Proteolysis-Targeting Chimaera Technology.
So Myoung Lee, Chung Hyo Kang, Sang Un Choi, Yeongrin Kim, Jong Yeon Hwang, Hye Gwang Jeong, Chi Hoon Park. ACS Synth Biol 2020
20
33

Rational discovery of molecular glue degraders via scalable chemical profiling.
Cristina Mayor-Ruiz, Sophie Bauer, Matthias Brand, Zuzanna Kozicka, Marton Siklos, Hana Imrichova, Ines H Kaltheuner, Elisa Hahn, Kristina Seiler, Anna Koren,[...]. Nat Chem Biol 2020
82
33

Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells.
Jan Krönke, Namrata D Udeshi, Anupama Narla, Peter Grauman, Slater N Hurst, Marie McConkey, Tanya Svinkina, Dirk Heckl, Eamon Comer, Xiaoyu Li,[...]. Science 2014
937
33

Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation.
Lu Lv, Peihao Chen, Longzhi Cao, Yamei Li, Zhi Zeng, Yue Cui, Qingcui Wu, Jiaojiao Li, Jian-Hua Wang, Meng-Qiu Dong,[...]. Elife 2020
47
33

Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4CRBN activity.
Quinlan L Sievers, Jessica A Gasser, Glenn S Cowley, Eric S Fischer, Benjamin L Ebert. Blood 2018
61
33

Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo.
Sarah A Richman, Liang-Chuan Wang, Edmund K Moon, Uday R Khire, Steven M Albelda, Michael C Milone. Mol Ther 2020
22
33

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.
Christine E Brown, Darya Alizadeh, Renate Starr, Lihong Weng, Jamie R Wagner, Araceli Naranjo, Julie R Ostberg, M Suzette Blanchard, Julie Kilpatrick, Jennifer Simpson,[...]. N Engl J Med 2016
853
33

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.
Reuben Benjamin, Charlotte Graham, Deborah Yallop, Agnieszka Jozwik, Oana C Mirci-Danicar, Giovanna Lucchini, Danielle Pinner, Nitin Jain, Hagop Kantarjian, Nicolas Boissel,[...]. Lancet 2020
83
33

Modulation of chimeric antigen receptor surface expression by a small molecule switch.
Alexandre Juillerat, Diane Tkach, Brian W Busser, Sonal Temburni, Julien Valton, Aymeric Duclert, Laurent Poirot, Stéphane Depil, Philippe Duchateau. BMC Biotechnol 2019
45
33

The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice.
Aisha Yesbolatova, Yuichiro Saito, Naomi Kitamoto, Hatsune Makino-Itou, Rieko Ajima, Risako Nakano, Hirofumi Nakaoka, Kosuke Fukui, Kanae Gamo, Yusuke Tominari,[...]. Nat Commun 2020
60
33

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
A Palumbo, S V Rajkumar, M A Dimopoulos, P G Richardson, J San Miguel, B Barlogie, J Harousseau, J A Zonder, M Cavo, M Zangari,[...]. Leukemia 2008
566
16

TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
Martin Jädersten, Leonie Saft, Alexander Smith, Austin Kulasekararaj, Sabine Pomplun, Gudrun Göhring, Anette Hedlund, Robert Hast, Brigitte Schlegelberger, Anna Porwit,[...]. J Clin Oncol 2011
326
16

Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
Ajai Chari, Attaya Suvannasankha, Joseph W Fay, Bertrand Arnulf, Jonathan L Kaufman, Jainulabdeen J Ifthikharuddin, Brendan M Weiss, Amrita Krishnan, Suzanne Lentzsch, Raymond Comenzo,[...]. Blood 2017
316
16

Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.
Michael S van der Veer, Michel de Weers, Berris van Kessel, Joost M Bakker, Shulamiet Wittebol, Paul W H I Parren, Henk M Lokhorst, Tuna Mutis. Haematologica 2011
158
16

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma.
Jia Ruan, Peter Martin, Bijal Shah, Stephen J Schuster, Sonali M Smith, Richard R Furman, Paul Christos, Amelyn Rodriguez, Jakub Svoboda, Jessica Lewis,[...]. N Engl J Med 2015
169
16

Risk of rash associated with lenalidomide in cancer patients: a systematic review of the literature and meta-analysis.
Beatrice Nardone, Shenhong Wu, Benjamin C Garden, Dennis P West, Lilian M Reich, Mario E Lacouture. Clin Lymphoma Myeloma Leuk 2013
27
16

Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide.
I N M Micallef, A D Ho, L M Klein, S Marulkar, P J Gandhi, G Calandra, P A McSweeney. Bone Marrow Transplant 2011
43
16

Arterial thrombosis in four patients treated with thalidomide.
Sarah L Scarpace, Theresa Hahn, Hilary Roy, Karen Brown, Pamela Paplham, Asher Chanan-Khan, Koen van Besien, Philip L McCarthy. Leuk Lymphoma 2005
39
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.